Lukas Hainz

Lukas Hainz

Biopharma Innovation Specialist
Lukas Hainz specializes in biopharmaceutical research and development. He unpacks research from clinical trials and explores regulatory affairs implications on the pharmaceutical industry, focusing on innovative therapies and patent development.
Can You Trust Google AI With Your Health?
Digital Health Can You Trust Google AI With Your Health?

In a moment of fear or uncertainty about a new symptom, millions of people turn to the internet for immediate answers, a behavior now fraught with a new and insidious risk posed by artificial intelligence. A comprehensive investigation into Google's AI Overviews feature has uncovered a systemic

Finger Lakes Radiology Breach Exposes Patient Medical Data
Imaging & Diagnostics Finger Lakes Radiology Breach Exposes Patient Medical Data

A recently disclosed data security incident at a prominent New York medical imaging provider has potentially exposed the sensitive personal and health information of an unknown number of patients and employees, highlighting the persistent cybersecurity challenges facing the healthcare industry.

What Defines the New Era of Healthcare IT?
Infrastructure & Management What Defines the New Era of Healthcare IT?

A fundamental shift is rearchitecting the global healthcare technology landscape, transforming what was once a series of discretionary upgrades into an urgent operational and financial necessity for providers worldwide. The era of siloed, department-specific software is definitively over, replaced

Can a Blood Test Predict Alzheimer's Decades Early?
Imaging & Diagnostics Can a Blood Test Predict Alzheimer's Decades Early?

The silent progression of Alzheimer's disease, often beginning decades before the first noticeable symptoms of memory loss appear, has long posed one of the greatest challenges in modern medicine. For patients and their families, the diagnosis frequently arrives too late, after significant and

US Medical Tariffs Undermine Public Health
Infrastructure & Management US Medical Tariffs Undermine Public Health

The rapid proliferation of at-home medical technology has empowered millions of Americans to take control of their well-being, transforming kitchens and living rooms into the front lines of preventative care. This shift promises a future of greater health autonomy, yet this progress is now

Is AI Therapy a Cure or a Digital Prison?
Digital Health Is AI Therapy a Cure or a Digital Prison?

Facing an unprecedented global mental health crisis, where over a billion people grapple with psychological conditions, a novel and technologically sophisticated solution has rapidly gained prominence, promising immediate relief at the touch of a screen. AI-powered therapists, accessible 24/7, are

UnitedHealth Stock Falls Amid Regulatory Pressure
Patient Care UnitedHealth Stock Falls Amid Regulatory Pressure

A sudden drop in UnitedHealth Group's stock during after-hours trading has cast a harsh light on the immense regulatory and financial pressures confronting the healthcare giant, signaling that even minor policy adjustments can have significant repercussions for market sentiment. The company's

U.S. Faces Worst Measles Outbreak in 25 Years
Digital Health U.S. Faces Worst Measles Outbreak in 25 Years

A preventable disease that was declared eliminated in the United States a quarter-century ago is now surging with alarming speed, pushing the nation's public health system to its limits and raising serious questions about the state of herd immunity. With the number of infections for 2025 climbing

Why Are Radiologists Outsourcing Their Billing?
Imaging & Diagnostics Why Are Radiologists Outsourcing Their Billing?

The intricate world of medical imaging requires immense focus and precision from radiologists, but an equally complex and often more frustrating challenge is unfolding far from the diagnostic screen in the back office. As reimbursement models evolve and administrative demands intensify, radiology

Analysts Call Trump's New Drug Deals Symbolic
Regulatory & Compliance Analysts Call Trump's New Drug Deals Symbolic

Today, we're speaking with James Maitland, an expert in healthcare innovation and the intricate dynamics between the pharmaceutical industry, government policy, and financial markets. We'll be exploring the recent wave of drug pricing deals between major pharmaceutical companies and the White

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later